Just Biotherapeutics

Business Services · Washington, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

454 N 34th St, Seattle, Washington, 9810...

Phone Number

(206) 651-5094

Revenue

$17.3 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Just Biotherapeutics

Just is an integrated design company focused on the technology of biotherapeutics, from molecule to manufacturing plant. The company believes that technological innovation will accelerate biotherapeutic development and dramatically reduce the cost of these vital medicines.Explore more
Just Biotherapeutics's Social MediaPopular SearchesJust Biotherapeutics IncJust biotherapeuticsJust-evotec Biologics IncEvotec BiologicsHangzhou Just Biotherapeutics (Just China)SIC Code 87,873NAICS Code 54,541Show more

Just Biotherapeutics Org Chart

PhoneEmail
GR
United States flag for contact location.

Senior Vice President, Global Head of Strateg...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
TJ
United States flag for contact location.

Alliance Manager

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Just Biotherapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Just Biotherapeutics

Compare insights from companies similar to Just Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Just Biotherapeutics

$17.3M
51-200
Private
$71M
2014
GR
Guy RachmuthSenior Vice President, Global Head of Strategic BD and Partnerships. Chief Business Officer
$112.7M
201-500
Private
$113.6M
2009
Thomas Castellano, Chief Financial Officer at Abzena
Thomas CastellanoChief Financial Officer
$26.9M
201-500
Private
$42.5M
2003
Peter Cowley, President at Cytovance Biologics
Peter CowleyPresident
$8.2M
11-50
Private
-
2018
RB
Ramon BioscaVice President, Commercial Operations
$7.3M
51-200
Private
-
2000
SC
Staci CarterAccount Executive
$6.1M
11-50
Private
-
2009
$5.4M
11-50
Private
-
2013
GC
Guoqing ChenPresident & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Just Biotherapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Just Biotherapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Just Biotherapeutics.

Just Biotherapeutics financials insights

Gather financial insights about Just Biotherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2016

Series A

$14M

2017

Series B

$57M

See All Just Biotherapeutics's Financials Insights

Just Biotherapeutics Tech Stack

A closer look at the technologies used by Just Biotherapeutics

Most Recent Scoops

Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Left Company
Management Move
See more scoops

Just Biotherapeutics News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Just Biotherapeutics

What is Just Biotherapeutics's official website?
Just Biotherapeutics's official website is www.justbiotherapeutics.com
What is Just Biotherapeutics's Revenue?
Just Biotherapeutics's revenue is $17.3 Million
What is Just Biotherapeutics's SIC code?
Just Biotherapeutics's SIC: 87,873
What is Just Biotherapeutics's NAICS code?
Just Biotherapeutics's NAICS: 54,541
How many employees does Just Biotherapeutics have?
Just Biotherapeutics has 51-200 employees
What industry does Just Biotherapeutics belong to?
Just Biotherapeutics is in the industry of: Business Services, Research & Development
What is Just Biotherapeutics competition?
Just Biotherapeutics top competitors include: Cytovance Biologics, Biocompare, JOINN Biologics US, G&P Biosciences
What companies has Just Biotherapeutics acquired?
Just Biotherapeutics has acquired the companies: Antares Pharma, EVOTEC, KINAXO Biotechnologies, Renovis
What technology does Just Biotherapeutics use?
Some of the popular technologies that Just Biotherapeutics uses are: Freshservice, Zingfit, DocuSign, PHP
How do I contact Just Biotherapeutics?
Just Biotherapeutics contact info: Phone number: (206) 651-5094 Website: www.justbiotherapeutics.com
What does Just Biotherapeutics do?

Just is an integrated design company focused on the technology of biotherapeutics, from molecule to manufacturing plant. The company believes that technological innovation will accelerate biotherapeutic development and dramatically reduce the cost of these vital medicines.... Read More

What are Just Biotherapeutics social media links?
Just Biotherapeutics Linkedin page
Who invested in Just Biotherapeutics?
Just Biotherapeutics has 11 investors including Bill & Melinda Gates Foundation, Lilly Asia Ventures, ARCH Venture Partners and Bill & Melinda Gates Foundation.
Is Just Biotherapeutics a public company?
Just Biotherapeutics is private company therefore does not currently have an official ticker symbol
See more information about Just Biotherapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.